NCT04737473

Brief Summary

Recently, a lot of side effects have been identified from the perioperative use of opioids. To remedy this, anesthesia research has recently focused on providing safe general anesthesia without opioids in a new concept or anesthetic technic called Opiod Free Anesthesia (OFA). Evidence on the effectiveness and safety of OFA is scarce in Africa, with no report from Cameroon.The aim of this study is to demonstrate the feasibility of an adapted OFA protocol as well as its efficacy and safety in very painful surgeries like gynaecology surgery in a low-resource setting.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2020

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

January 3, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 3, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 28, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2021

Completed
Last Updated

February 3, 2021

Status Verified

January 1, 2021

Enrollment Period

1.7 years

First QC Date

January 3, 2021

Last Update Submit

January 31, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intraoperative variables

    The success rate of OFA (defined as no intraoperative administration of opioids).

    9 months

Secondary Outcomes (1)

  • Postoperative variables

    9 months

Study Arms (2)

Opiod Free Anesthesia (OFA) group

EXPERIMENTAL

The OFA protocol will entailed induction of anesthesia intravenously by the administration of the following drugs: magnesium sulfate 40mg/kg (without exceeding 2.5g), lidocaine 1.5mg/kg, ketamine 25mg, propofol 1.5-2mg/kg, dexamethasone 8mg and rocuronium 0.6mg/kg. Anesthesia will be maintained using isofluorane through volume controlled ventilation, and a mixture of magnesium sulfate 40mg/kg (without exceeding 2.5g/24h), lidocaine 1.5mg/kg, ketamine 25mg, and clonidine 1ug/kg in an electric pump syringe at 10 - 15 ml/h.

Drug: Opiod Free Anesthesia

General anesthesia (GA) group

ACTIVE COMPARATOR

The GA protocol described in the intervention arm

Drug: Opiod Free Anesthesia

Interventions

The OFA protocol will entailed induction of anesthesia intravenously by the administration of the following drugs: magnesium sulfate 40mg/kg (without exceeding 2.5g), lidocaine 1.5mg/kg, ketamine 25mg, propofol 1.5-2mg/kg, dexamethasone 8mg and rocuronium

Also known as: General anesthesia (GA)
General anesthesia (GA) groupOpiod Free Anesthesia (OFA) group

Eligibility Criteria

Age21 Years - 70 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemales aged between 21 to 70 years old
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiology (ASA) grade I and II patients
  • Patients undergoing an elective myomectomy, hysterectomy, ovarian cystectomy or total mastectomy.
  • Patients who will be operated for benign pathologies or localized malignancies

You may not qualify if:

  • Past history of allergy to any of the anesthetic drugs
  • Refusal to consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yaounde Gynaeco-Obstetric and Pediatric Hospital

Yaoundé, Centre Region, 237, Cameroon

RECRUITING

Related Publications (3)

  • Guinot PG, Spitz A, Berthoud V, Ellouze O, Missaoui A, Constandache T, Grosjean S, Radhouani M, Anciaux JB, Parthiot JP, Merle JP, Nowobilski N, Nguyen M, Bouhemad B. Effect of opioid-free anaesthesia on post-operative period in cardiac surgery: a retrospective matched case-control study. BMC Anesthesiol. 2019 Jul 31;19(1):136. doi: 10.1186/s12871-019-0802-y.

  • Frauenknecht J, Kirkham KR, Jacot-Guillarmod A, Albrecht E. Analgesic impact of intra-operative opioids vs. opioid-free anaesthesia: a systematic review and meta-analysis. Anaesthesia. 2019 May;74(5):651-662. doi: 10.1111/anae.14582. Epub 2019 Feb 25.

  • Tochie JN, Bengono Bengono RS, Metogo JM, Ndikontar R, Ngouatna S, Ntock FN, Minkande JZ. The efficacy and safety of an adapted opioid-free anesthesia regimen versus conventional general anesthesia in gynecological surgery for low-resource settings: a randomized pilot study. BMC Anesthesiol. 2022 Oct 24;22(1):325. doi: 10.1186/s12871-022-01856-6.

MeSH Terms

Interventions

Anesthesia, General

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and Analgesia

Study Officials

  • Jacqueline Ze Minkande, MD

    University of Yaounde I

    STUDY DIRECTOR

Central Study Contacts

Joel Noutakdie Tochie, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor/Anesthetist

Study Record Dates

First Submitted

January 3, 2021

First Posted

February 3, 2021

Study Start

January 6, 2020

Primary Completion

September 28, 2021

Study Completion

December 5, 2021

Last Updated

February 3, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations